{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:24:12Z","timestamp":1775309052631,"version":"3.50.1"},"reference-count":75,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Agency\u2014Poland","award":["2020\/ABM\/COVID19\/0059"],"award-info":[{"award-number":["2020\/ABM\/COVID19\/0059"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The pathophysiology of the severe course of COVID-19 is multifactorial and not entirely elucidated. However, it is well known that the hyperinflammatory response and cytokine storm are paramount events leading to further complications. In this paper, we investigated the vascular response in the pathophysiology of severe COVID-19 and aimed to identify novel biomarkers predictive of ICU admission. The study group consisted of 210 patients diagnosed with COVID-19 (age range: 18\u201393; mean \u00b1 SD: 57.78 \u00b1 14.16), while the control group consisted of 80 healthy individuals. We assessed the plasma concentrations of various vascular factors using the Luminex technique. Then, we isolated RNA from blood mononuclear cells and performed a bioinformatics analysis investigating various processes related to vascular response, inflammation and angiogenesis. Our results confirmed that severe COVID-19 is associated with vWF\/ADAMTS 13 imbalance. High plasma concentrations of VEGFR and low DPP-IV may be potential predictors of ICU admission. SARS-CoV-2 infection impairs angiogenesis, hinders the generation of nitric oxide, and thus impedes vasodilation. The hypercoagulable state develops mainly in the early stages of the disease, which may contribute to the well-established complications of COVID-19.<\/jats:p>","DOI":"10.3390\/ijms242317003","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T09:39:12Z","timestamp":1701337152000},"page":"17003","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-8705","authenticated-orcid":false,"given":"Ewa","family":"Pius-Sadowska","sequence":"first","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8695-8863","authenticated-orcid":false,"given":"Piotr","family":"Kulig","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nied\u017awied\u017a","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-5844","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Baumert","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-7473","authenticated-orcid":false,"given":"Karolina","family":"\u0141uczkowska","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Rogi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sobu\u015b","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Ula\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0142osz","family":"Kawa","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-9741","authenticated-orcid":false,"given":"Edyta","family":"Paczkowska","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arko\u0144ska 4 Street, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Machali\u0144ska","sequence":"additional","affiliation":[{"name":"First Department of Ophthalmology, Pomeranian Medical University, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Machali\u0144ski","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University in Szczecin, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus\u2013Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamainternmed.2021.7949","article-title":"Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar","volume":"182","author":"Butt","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_3","first-page":"49","article-title":"Delta variant of COVID-19: A simple explanation","volume":"2021","author":"Hendaus","year":"2021","journal-title":"Qatar Med. J."},{"key":"ref_4","first-page":"8012","article-title":"Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e28224","DOI":"10.1002\/jmv.28224","article-title":"Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_6","first-page":"e942244","article-title":"Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2","volume":"29","author":"Parums","year":"2023","journal-title":"Med. Sci. Monit."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","article-title":"Clinical manifestations of COVID-19 in the general population: Systematic review","volume":"133","author":"Filho","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.3346\/jkms.2020.35.e174","article-title":"Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients","volume":"35","author":"Lee","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/postgradmedj-2020-138577","article-title":"COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment","volume":"97","author":"Parasher","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104371","DOI":"10.1016\/j.jcv.2020.104371","article-title":"Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis","volume":"127","author":"Hu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: An overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: An overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Narazaki, M., and Kishimoto, T. (2014). IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a016295"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/rccm.202107-1774OC","article-title":"COVID-19\u2013associated Lung Microvascular Endotheliopathy: A \u201cFrom the Bench\u201d Perspective","volume":"206","author":"Joffre","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: From basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pius-Sadowska, E., Nied\u017awied\u017a, A., Kulig, P., Baumert, B., Sobu\u015b, A., Rogi\u0144ska, D., \u0141uczkowska, K., Ula\u0144czyk, Z., Wn\u0119k, S., and Karolak, I. (2022). CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911338"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.12998\/wjcc.v10.i27.9556","article-title":"Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic","volume":"10","author":"Pazdernik","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"780872","DOI":"10.3389\/fendo.2022.780872","article-title":"Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MCP.0000000000000834","article-title":"Chronic obstructive pulmonary disease and COVID-19: Interrelationships","volume":"28","author":"Singh","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Poudel, R., Daniels, L.B., DeFilippis, A.P., Hamburg, N.M., Khan, Y., Keith, R.J., Kumar, R.S., Strokes, A.C., Robertson, R.M., and Bhatnagar, A. (2022). Smoking is associated with increased risk of cardiovascular events, disease severity, and mortality among patients hospitalized for SARS-CoV-2 infections. Santulli G, editor. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0270763"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Statsenko, Y., Al Zahmi, F., Habuza, T., Almansoori, T.M., Smetanina, D., Simiyu, G.L., Gorkom, K.N.-V., Ljubisavljevic, M., Awawdeh, R., and Elshekhali, H. (2022). Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.777070"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"662746","DOI":"10.3389\/fonc.2021.662746","article-title":"More Severe COVID-19 in Patients with Active Cancer: Results of a Multicenter Cohort Study","volume":"11","author":"Monari","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sienko, J., Marczak, I., Kotowski, M., Bogacz, A., Tejchman, K., Sienko, M., and Kotfis, K. (2022). Association of ACE2 Gene Variants with the Severity of COVID-19 Disease\u2014A Prospective Observational Study. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191912622"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1038\/s41598-022-08853-2","article-title":"Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients","volume":"12","author":"Seibert","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/jalm\/jfab042","article-title":"Role of von Willebrand Factor in COVID-19 Associated Coagulopathy","volume":"6","author":"Mei","year":"2021","journal-title":"J. Appl. Lab. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.thromres.2020.05.032","article-title":"ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients","volume":"192","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sillen, M., and Declerck, P.J. (2021). A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052721"},{"key":"ref_38","first-page":"1","article-title":"Plasminogen Activator Inhibitor-1 Levels as an Indicator of Severity and Mortality for COVID-19","volume":"10","author":"Baycan","year":"2023","journal-title":"North. Clin. Istanb."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_40","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF)\u2014Key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.ATV.0000260001.55955.6c","article-title":"VEGFR-1 and -2 Regulate Inflammation, Myocardial Angiogenesis, and Arteriosclerosis in Chronically Rejecting Cardiac Allografts","volume":"27","author":"Raisky","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2100377","DOI":"10.1183\/13993003.00377-2021","article-title":"Between inflammation and thrombosis: Endothelial cells in COVID-19","volume":"58","author":"Birnhuber","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Miggiolaro, A.F.R.S., Da Silva, F.P.G., Wiedmer, D.B., Godoy, T.M., Borges, N.H., Piper, G.W., Oricil, A.G.G., Klein, C.K., Hlatchuk, E.C., and Dagostini, J.C.H. (2023). COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction. Viruses, 15.","DOI":"10.3390\/v15030706"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sayin Kocakap, D.B., Kaygusuz, S., Aksoy, E., \u015eah\u00efN, \u00d6., Ba\u00e7\u00e7io\u011flu, A., Ek\u00efC\u00ef, A., Kalpakl\u0131o\u011flu, A.F., Ekici, M.S., G\u00fcl, S., and Ka\u00e7maz, B. (2023). Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner. Microbes Infect., 105188.","DOI":"10.1016\/j.micinf.2023.105188"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Flatt, P.R. (2008). Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes. Front. Biosci., 13.","DOI":"10.2741\/2956"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3132\/dvdr.2006.024","article-title":"Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes","volume":"3","author":"Green","year":"2006","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s10787-022-01078-9","article-title":"Is sitagliptin effective for SARS-CoV-2 infection: False or true prophecy?","volume":"30","author":"Alomair","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jinf.2013.04.007","article-title":"Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4","volume":"67","author":"Jiang","year":"2013","journal-title":"J. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Raha, A.A., Chakraborty, S., Henderson, J., Mukaetova-Ladinska, E., Zaman, S., Trowsdale, J., and Raha-Chowdhury, R. (2020). Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci. Rep., 40.","DOI":"10.1042\/BSR20203092"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/s41366-020-00689-y","article-title":"Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections","volume":"44","author":"Schlicht","year":"2020","journal-title":"Int. J. Obes."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2478\/acph-2021-0013","article-title":"Sitagliptin: A potential drug for the treatment of COVID-19?","volume":"71","author":"Bardaweel","year":"2021","journal-title":"Acta Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1874467214666210902115650","article-title":"Impact of Sitagliptin on Non-diabetic COVID-19 Patients","volume":"15","author":"Qusty","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"794382","DOI":"10.3389\/fendo.2021.794382","article-title":"A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19","volume":"12","author":"Abuhasira","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"108163","DOI":"10.1016\/j.diabres.2020.108163","article-title":"Letter to the editor in response to the article \u201cCOVID-19 and diabetes: Can DPP4 inhibition play a role?\u201d","volume":"163","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.therap.2021.01.051","article-title":"DPP-4 inhibitors and severe course of illness in patients with COVID-19","volume":"76","author":"Bouhanick","year":"2021","journal-title":"Therapies"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5501\/wjv.v11.i6.399","article-title":"Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control","volume":"11","author":"Narayanan","year":"2022","journal-title":"World J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/thoraxjnl-2020-216714","article-title":"Pulmonary vascular proliferation in patients with severe COVID-19: An autopsy study","volume":"76","author":"Bardi","year":"2021","journal-title":"Thorax"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric Oxide and Endothelial Dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/jvi.71.7.5227-5235.1997","article-title":"Inhibition of Japanese encephalitis virus infection by nitric oxide: Antiviral effect of nitric oxide on RNA virus replication","volume":"71","author":"Lin","year":"1997","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Akaberi, D., Krambrich, J., Ling, J., Luni, C., Hedenstierna, G., J\u00e4rhult, J.D., Lennerstrand, J., and Lundkvist, \u00c5. (2020). Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol., 37.","DOI":"10.1016\/j.redox.2020.101734"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1164\/rccm.202005-1906ED","article-title":"Home Nitric Oxide Therapy for COVID-19","volume":"202","author":"Alvarez","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gelzo, M., Scial\u00f2, F., Cacciapuoti, S., Pinchera, B., De Rosa, A., Cernera, G., Comegna, M., Tripodi, L., Moriello, N.S., and Mormile, M. (2022). Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?. Viruses, 14.","DOI":"10.3390\/v14030534"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3892\/ol.2022.13240","article-title":"Biological response of adrenal carcinoma and melanoma cells to mitotane treatment","volume":"23","author":"Stelcer","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Majchrzak-Celi\u0144ska, A., Kleszcz, R., Studzi\u0144ska-Sroka, E., \u0141ukaszyk, A., Szoszkiewicz, A., Stelcer, E., Jopek, K., Rucinski, M., Cielecka-Piontek, J., and Krajka-Ku\u017aniak, V. (2022). Lichen Secondary Metabolites Inhibit the Wnt\/\u03b2-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells, 11.","DOI":"10.3390\/cells11071084"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Dennis, G., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C., and Lempicki, R.A. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4.","DOI":"10.1186\/gb-2003-4-5-p3"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/bioinformatics\/btt487","article-title":"RDAVIDWebService: A versatile R interface to DAVID","volume":"29","author":"Fresno","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_75","unstructured":"R Core Team (2019). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/17003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:07Z","timestamp":1760132107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/17003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":75,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijms242317003"],"URL":"https:\/\/doi.org\/10.3390\/ijms242317003","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}